OEGSTGEEST, The Netherlands, ISA Pharmaceuticals B.V., a clinical stage biotech company developing immunotherapies to treat cancers and infectious diseases, is pleased to announce that its representatives will be participating and presenting at the following business conferences in May 2022.
LSX World Leaders Congress
- Date: 10-11 May 2022, London, UK
- Panel Presentation by: Anton Mat, Director Business Development, ISA Pharmaceuticals
- Title: Key Multi-Stakeholder Considerations In Early-Stage Commercial Deal-Making
- Date & Time: Tuesday, 10 May 2022, 14.30pm BST
Bio€quity Europe
- Date: 16-18 May 2022, Milan, Italy
- Presentation by: Gerben Moolhuizen, Chief Executive Officer, ISA Pharmaceuticals
- Date & Time: Virtual, pre-recorded presentation available any time via the partnering system
UBS Global Healthcare Conference
- Date: 23-25 May 2022, New York, US
- Presentation by: Gerben Moolhuizen, Chief Executive Officer, ISA Pharmaceuticals
- Title: ISA Pharmaceuticals Company Presentation
- Date & Time: Monday, 23 May 2022, 07.45am ET
If you would like to meet with the ISA Pharmaceuticals team at any of the above events, please contact us at the details provided below. For more information, please visit us at isa-pharma.com.
ISA Pharmaceuticals is an immunotherapy company developing treatments for various cancers and infectious diseases. ISA Pharma has best-in-class technology to stimulate and activate the human immune system, specifically T cells, to fight diseased or infected cells. Its lead asset ISA101b is in late-stage clinical trials for human papillomavirus type 16 (HPV16)-induced cancers in a collaboration with US pharmaceutical company Regeneron.
Other assets are in preclinical stage development and include immunotherapies to treat patients that suffer from chronic hepatitis B infections, cancers that over-express PRAME, cancers caused by other HPV types than HPV16, or SARS-CoV2 infections. For more information, please visit www.isa-pharma.com.
About LSX World Leaders Congress
LSX World Congress gathers the founders and CEOs of innovative start-ups through to healthcare giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.
It is an industry-leading gathering with qualified 1:1 partnering at its core, connecting the biotech, healthtech and medtech industry c-suite with the sector’s most active pharma, investors and health technology BD&L teams, R&D leaders, KOLs and top tier service companies who are driving the sector forward.
Bio€quity is the industry’s premier international showcase for financial dealmakers and pharmaceutical executives to assess and network with rising biotechs. More than 80 hand-picked companies will present their stories and participate in the thought-leading program. The European Congress on Biotechnology is the leading congress for academic and industrial biotechnologists in Europe.
About UBS Global Healthcare Conference
Three-day conference bringing together investors and 100+ companies across the healthcare services and life sciences sectors for presentations as well as thematic panels, and concurrent one-on-one and group meetings.
This article was shared with Prittle Prattle News as a Press Release PRNewswire.
